143 related articles for article (PubMed ID: 37765252)
1. Development of a Carvedilol Oral Liquid Formulation for Paediatric Use.
Chiclana-Rodríguez B; Garcia-Montoya E; Rouaz-El Hajoui K; Romero-Obon M; Nardi-Ricart A; Suñé-Pou M; Suñé-Negre JM; Pérez-Lozano P
Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765252
[TBL] [Abstract][Full Text] [Related]
2. Palatability and Stability Studies to Optimize a Carvedilol Oral Liquid Formulation for Pediatric Use.
Chiclana-Rodríguez B; Garcia-Montoya E; Romero-Obon M; Rouaz-El-Hajoui K; Nardi-Ricart A; Suñé-Pou M; Suñé-Negre JM; Pérez-Lozano P
Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258041
[TBL] [Abstract][Full Text] [Related]
3. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
[TBL] [Abstract][Full Text] [Related]
4. Flexible New Dosage Forms Containing Carvedilol for the Treatment of Patients with Cardiovascular Disorders: Development, Stability, Palatability, and Microbiological Studies.
Operto MA; Maggio R; Leonardi D; Vignaduzzo S
AAPS PharmSciTech; 2023 Jul; 24(6):159. PubMed ID: 37498506
[TBL] [Abstract][Full Text] [Related]
5. Critical Aspects in the Preparation of Extemporaneous Flecainide Acetate Oral Solution for Paediatrics.
Casiraghi A; Centin G; Selmin F; Picozzi C; Minghetti P; Zanon D
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834378
[TBL] [Abstract][Full Text] [Related]
6. Formulating a poorly water soluble drug into an oral solution suitable for paediatric patients; lorazepam as a model drug.
van der Vossen AC; van der Velde I; Smeets OS; Postma DJ; Eckhardt M; Vermes A; Koch BC; Vulto AG; Hanff LM
Eur J Pharm Sci; 2017 Mar; 100():205-210. PubMed ID: 28126558
[TBL] [Abstract][Full Text] [Related]
7. Furosemide ethanol-free oral solutions for paediatric use: formulation, HPLC method and stability study.
Zahálka L; Klovrzová S; Matysová L; Šklubalová Z; Solich P
Eur J Hosp Pharm; 2018 May; 25(3):144-149. PubMed ID: 31157009
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective glucuronidation of carvedilol by Chinese liver microsomes.
You LY; Yu CN; Xie SG; Chen SQ; Zeng S
J Zhejiang Univ Sci B; 2007 Oct; 8(10):756-64. PubMed ID: 17910120
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound.
Neugebauer G; Akpan W; Kaufmann B; Reiff K
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S108-11. PubMed ID: 1974498
[TBL] [Abstract][Full Text] [Related]
10. Development of carvedilol-cyclodextrin inclusion complexes using fluid-bed granulation: a novel solid-state complexation alternative with technological advantages.
Alonso EC; Riccomini K; Silva LA; Galter D; Lima EM; Durig T; Taveira SF; Martins FT; Cunha-Filho MS; Marreto RN
J Pharm Pharmacol; 2016 Oct; 68(10):1299-309. PubMed ID: 27465985
[TBL] [Abstract][Full Text] [Related]
11. A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding.
Rush SD; Vernak C; Zhao F
Int J Pharm Compd; 2017; 21(1):83-87. PubMed ID: 28346201
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate.
Lopalco A; Curci A; Lopedota A; Cutrignelli A; Laquintana V; Franco M; Denora N
Eur J Pharm Sci; 2019 Jan; 127():339-350. PubMed ID: 30447284
[TBL] [Abstract][Full Text] [Related]
13. Stability of Omeprazole Extemporaneous Oral Solution in Chopin Base.
Spennacchio A; Lopedota AA; la Forgia FM; Fontana S; Denora N; Lopalco A
Int J Pharm Compd; 2023; 27(3):250-255. PubMed ID: 37267528
[TBL] [Abstract][Full Text] [Related]
14. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.
Pabari RM; McDermott C; Barlow J; Ramtoola Z
Clin Ther; 2012 Nov; 34(11):2221-9. PubMed ID: 23149007
[TBL] [Abstract][Full Text] [Related]
15. Formulation, Physical Stability, and the Clinical Effectiveness of Extemporaneous Ivermectin Oral Solution.
Zaid AN; Zaaror YA; Qaddumi A; Ratrout A; Ahmad A; Hamad E; Kittana N
Int J Pharm Compd; 2021; 25(6):523-527. PubMed ID: 34807848
[TBL] [Abstract][Full Text] [Related]
16. Extemporaneous sotalol hydrochloride oral solutions for use in paediatric cardiology: formulation and stability study.
Klovrzová S; Zahálka L; Kříž T; Zahálková O; Matysová L; Šklubalová Z; Horák P
Eur J Hosp Pharm; 2016 Jan; 23(1):33-37. PubMed ID: 31156811
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol stability in paediatric oral liquid formulations.
Buontempo F; Bernabeu E; Glisoni RJ; Quiroga E; Bregni C; Chiappetta DA
Farm Hosp; 2010; 34(6):293-7. PubMed ID: 20418137
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol recovers normal blood pressure variability in rats with myocardial infarction.
Dantas EM; Pimentel EB; Andreão RV; Cichoni BS; Gonçalves CP; Zaniqueli Ddos A; Baldo MP; Rodrigues SL; Mill JG
Auton Neurosci; 2013 Oct; 177(2):231-6. PubMed ID: 23759752
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of carvacrol/β-cyclodextrin complex protects against 6-hydroxydopamine-induced dopaminergic denervation.
Tiefensee Ribeiro C; Gasparotto J; Petiz LL; Brum PO; Peixoto DO; Kunzler A; da Rosa Silva HT; Bortolin RC; Almeida RF; Quintans-Junior LJ; Araújo AA; Moreira JCF; Gelain DP
Neurochem Int; 2019 Jun; 126():27-35. PubMed ID: 30849398
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
Parikh T; Sandhu HK; Talele TT; Serajuddin AT
Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
